[Anti-tumour necrosis factor agents and tuberculosis risk: is there a difference? What are the most appropriate screening methods?]
- PMID: 20607636
- DOI: 10.1055/s-0029-1245326
[Anti-tumour necrosis factor agents and tuberculosis risk: is there a difference? What are the most appropriate screening methods?]
Comment on
-
Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective French Research Axed on Tolerance of Biotherapies registry.Arthritis Rheum. 2009 Jul;60(7):1884-94. doi: 10.1002/art.24632. Arthritis Rheum. 2009. PMID: 19565495 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources